AIMBE’s Industry Council, chaired by Dr. SuPing Lyu, is leading the charge to highlight the importance of Per- and Polyfluorinated Substances (PFAS) to the medical device industry. These so-called “forever chemicals” are rightfully being scrutinized to protect our health and environment; however, a very small number of these chemicals play critical roles in making sure that our medical devices save tens of millions of patients’ lives. On January 30, 2024, AIMBE will host a roundtable meeting to gather stakeholders to discuss the use of PFAS in medical devices and how they may be impacted by supply and pending regulatory changes. Perspectives including suppliers/processors of PFAS, medical device companies (users of PFAS), federal agencies (e.g., FDA, NIH, NIST, EPA, etc.), academia, public health, policy, and more will be represented. The goal of the session is to increase the understanding and awareness of the impacts of PFAS supply and regulatory changes across these different landscapes. A congressional lunch briefing, hosted by AIMBE, will be held on the same topic to educate lawmakers and staffers about the importance of fluorinated polymers to live-saving medical devices.